Preventive Services Panel Advises Against Broad BRCA Testing: 'Family History' Should Guide Testing | GenomeWeb

NEW YORK (GenomeWeb News) – An independent clinical advisory panel has recommended against genetic counseling and testing focused for BRCA status for "the vast majority" of American women, and advised that only women who with strong family histories of cancer should talk to their doctors about their risk and possibly getting genetically tested.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Intelligence officials in the US have added gene editing to a list of weapons of mass destruction.

In Cell this week: characterization of functional genomic features in breast cancer cell lines, epigenetic pattern linked to obesity, and more.

President Obama's proposed budget for fiscal year 2017 includes an increase for NIH, but seeks some of it as mandatory funding.

Sure Genomics begins to offer direct-to-consumer genome sequencing for $2,500.

Mar
03
Sponsored by
Agilent Technologies

This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.